HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Giuseppe Pelosi Selected Research

Mesothelioma

1/2017The differential diagnosis between pleural sarcomatoid mesothelioma and spindle cell/pleomorphic (sarcomatoid) carcinomas of the lung: evidence-based guidelines from the International Mesothelioma Panel and the MESOPATH National Reference Center.
1/2015Inference on germline BAP1 mutations and asbestos exposure from the analysis of familial and sporadic mesothelioma in a high-risk area.
6/2013ΔNp63 (p40) distribution inside lung cancer: a driver biomarker approach to tumor characterization.
6/2010Study of inorganic particles, fibers, and asbestos bodies by variable pressure scanning electron microscopy with annexed energy dispersive spectroscopy and micro-Raman spectroscopy in thin sections of lung and pleural plaque.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Giuseppe Pelosi Research Topics

Disease

88Neoplasms (Cancer)
02/2024 - 05/2002
33Carcinoma (Carcinomatosis)
10/2021 - 05/2002
29Lung Neoplasms (Lung Cancer)
01/2021 - 11/2003
21Carcinoid Tumor (Carcinoid)
05/2024 - 11/2003
21Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
04/2024 - 11/2003
14Neuroendocrine Tumors (Neuroendocrine Tumor)
03/2021 - 03/2005
12Adenocarcinoma
01/2024 - 01/2006
10Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2024 - 01/2006
10Breast Neoplasms (Breast Cancer)
01/2022 - 06/2003
10Small Cell Carcinoma
01/2020 - 11/2003
5Adenosquamous Carcinoma
10/2021 - 06/2011
5Colorectal Neoplasms (Colorectal Cancer)
10/2018 - 03/2008
5Neoplasm Metastasis (Metastasis)
11/2017 - 09/2005
5Small Cell Lung Carcinoma (Small Cell Lung Cancer)
04/2011 - 05/2002
4Adenocarcinoma of Lung
12/2021 - 12/2013
4Mesothelioma
01/2017 - 06/2010
4Large Cell Carcinoma
06/2013 - 04/2008
3Inflammation (Inflammations)
01/2024 - 03/2010
3Neuroendocrine Carcinoma
03/2021 - 12/2005
3Prostatic Neoplasms (Prostate Cancer)
11/2019 - 05/2007
3Hyperplasia
11/2019 - 08/2011
3Disease Progression
04/2016 - 05/2007
3Carcinosarcoma
06/2013 - 04/2012
3Sarcoma (Soft Tissue Sarcoma)
04/2011 - 05/2004
3Lymphatic Metastasis
03/2006 - 11/2003
2Idiopathic Pulmonary Fibrosis
06/2022 - 03/2010
2Retinoblastoma (Glioblastoma, Retinal)
01/2019 - 07/2017
2Mucinous Adenocarcinoma (Mucinous Carcinoma)
04/2017 - 08/2014
2Melanoma (Melanoma, Malignant)
01/2015 - 02/2012
2Pulmonary Blastoma
09/2012 - 04/2012
2Endodermal Sinus Tumor (Endodermal Sinus Tumors)
06/2011 - 07/2006

Drug/Important Bio-Agent (IBA)

17Biomarkers (Surrogate Marker)IBA
01/2022 - 06/2003
11Proteins (Proteins, Gene)FDA Link
01/2019 - 11/2003
9Ki-67 Antigen (Ki 67 Antigen)IBA
05/2024 - 09/2003
7Messenger RNA (mRNA)IBA
11/2021 - 01/2006
7DNA (Deoxyribonucleic Acid)IBA
01/2019 - 11/2003
7VimentinIBA
07/2017 - 09/2003
6SynaptophysinIBA
10/2021 - 05/2003
6ErbB Receptors (EGF Receptor)IBA
12/2013 - 12/2004
6TamoxifenFDA LinkGeneric
11/2009 - 06/2003
6fascinIBA
04/2007 - 05/2003
5Chromogranin AIBA
04/2017 - 05/2003
5Protein Isoforms (Isoforms)IBA
11/2013 - 07/2006
4Thyroid Nuclear Factor 1IBA
01/2019 - 06/2011
4MucinsIBA
01/2018 - 05/2009
4Eosine Yellowish-(YS) (Eosin)IBA
10/2017 - 02/2005
4Hematoxylin (Haematoxylon)IBA
10/2017 - 02/2005
4AsbestosIBA
01/2016 - 01/2006
4Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
01/2016 - 05/2007
4Gefitinib (Iressa)FDA Link
12/2013 - 02/2005
3Anaplastic Lymphoma KinaseIBA
04/2024 - 09/2012
3CateninsIBA
10/2021 - 04/2016
3Coloring Agents (Dyes)IBA
10/2017 - 05/2009
3Gonadal Steroid Hormones (Sex Hormones)IBA
04/2017 - 07/2006
3Keratin-7 (Cytokeratin 7)IBA
04/2017 - 06/2009
3ChromatinIBA
01/2017 - 02/2005
3Cadherins (E-Cadherin)IBA
04/2016 - 11/2003
3MicroRNAs (MicroRNA)IBA
10/2015 - 08/2011
3Erlotinib Hydrochloride (CP 358,774)FDA Link
02/2015 - 11/2006
3ParaffinIBA
06/2014 - 04/2008
3Insulin-Like Growth Factor I (IGF-1)IBA
08/2009 - 06/2003
3Hormones (Hormone)IBA
05/2007 - 05/2003
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2022 - 11/2019
2Antineoplastic Agents (Antineoplastics)IBA
01/2022 - 01/2016
2Histones (Histone)IBA
03/2021 - 01/2017
2B7-H1 AntigenIBA
01/2021 - 01/2020
2xylometazoline (stas)IBA
01/2020 - 11/2019
2Circulating MicroRNAIBA
10/2019 - 10/2015
2ChromograninsIBA
01/2019 - 04/2011
2GemcitabineFDA Link
03/2018 - 04/2011
2Oncogene Proteins (Oncogene Protein)IBA
11/2017 - 01/2016
2Nuclear Proteins (Protein, Nuclear)IBA
11/2017 - 04/2017
2Cyclin D1IBA
07/2017 - 12/2005
2Colloids (Colloid)IBA
04/2017 - 08/2014
2Progesterone Receptors (Progesterone Receptor)IBA
04/2017 - 05/2002
2PlasticsIBA
12/2016 - 06/2007
2Alkaline PhosphataseIBA
04/2016 - 07/2006
2Cisplatin (Platino)FDA LinkGeneric
04/2016 - 05/2010
2Phosphotransferases (Kinase)IBA
04/2015 - 05/2008
2Monoclonal AntibodiesIBA
01/2015 - 11/2003
2LigandsIBA
01/2015 - 08/2008
2AntibodiesIBA
08/2014 - 12/2010
2Tyrosine Kinase InhibitorsIBA
04/2014 - 11/2006
2Cetuximab (Erbitux)FDA Link
01/2014 - 03/2008
2Imatinib Mesylate (Gleevec)FDA Link
08/2013 - 08/2008
2Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
02/2012 - 06/2004
2DesmocollinsIBA
11/2011 - 05/2009
2DesminIBA
04/2011 - 09/2003

Therapy/Procedure

29Therapeutics
04/2024 - 05/2002
15Drug Therapy (Chemotherapy)
01/2022 - 05/2002
5Immunotherapy
12/2021 - 01/2015
4Neoadjuvant Therapy
01/2020 - 11/2004
3Radiotherapy
11/2017 - 05/2002
3Induction Chemotherapy
11/2017 - 12/2004
3Adjuvant Chemotherapy
04/2016 - 11/2006
3Lymph Node Excision (Lymph Node Dissection)
04/2011 - 03/2006
3Pneumonectomy (Lung Volume Reduction)
03/2010 - 01/2005
2Chemoprevention
11/2019 - 11/2003
2Lasers (Laser)
03/2018 - 05/2014
2Precision Medicine
01/2018 - 06/2014